M. Cappell
The American journal of gastroenterology, 2020
markers (for example, serologic and fecal inflammatory markers, rather than colonoscopy in IBD)may allow for enrollment and assessment during even such disrupted periods, thereby ensuring fewer patients are denied what may be their only window to receive a novel treatment. Use of clinical research centers rather than hospital-based practices may minimize the need for contact with the healthcare system in the context of these clinical trials. Indeed, such tools, although developed for the pandemic, may confer the added bonus of increasing the portability of these trials, making them more accessible to deserving patients worldwide.
Cited by 3 publications.
Field of study: Medicine